Afeyan Noubar is of Moderna, Inc.. Currently has a direct ownership of 2.22 Million shares of MRNA, which is worth approximately $121 Million. The most recent transaction as insider was on Sep 20, 2023, when has been sold 15,000 shares (Common Stock) at a price of $104.9 per share, resulting in proceeds of $1,573,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.22M
0% 3M change
3.59% 12M change
Total Value Held $121 Million

AFEYAN NOUBAR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 20 2023
SELL
Open market or private sale
$1,573,500 $104.9 p/Share
15,000 Reduced 0.68%
2,206,931 Common Stock
Sep 13 2023
SELL
Open market or private sale
$1,667,550 $111.17 p/Share
15,000 Reduced 0.67%
2,221,931 Common Stock
Sep 06 2023
SELL
Open market or private sale
$1,621,200 $108.08 p/Share
15,000 Reduced 0.75%
1,982,209 Common Stock
Aug 30 2023
SELL
Open market or private sale
$1,739,400 $115.96 p/Share
15,000 Reduced 0.75%
1,997,209 Common Stock
Aug 23 2023
SELL
Open market or private sale
$1,721,700 $114.78 p/Share
15,000 Reduced 0.74%
2,012,209 Common Stock
Aug 16 2023
SELL
Open market or private sale
$977,099 $97.71 p/Share
10,000 Reduced 0.49%
2,027,209 Common Stock
Aug 02 2023
SELL
Open market or private sale
$1,681,200 $112.08 p/Share
15,000 Reduced 0.73%
2,037,209 Common Stock
Jul 26 2023
SELL
Open market or private sale
$1,807,050 $120.47 p/Share
15,000 Reduced 0.73%
2,052,209 Common Stock
Jul 19 2023
SELL
Open market or private sale
$1,877,400 $125.16 p/Share
15,000 Reduced 0.72%
2,067,209 Common Stock
Jul 12 2023
SELL
Open market or private sale
$1,888,500 $125.9 p/Share
15,000 Reduced 0.72%
2,082,209 Common Stock
Jul 05 2023
SELL
Open market or private sale
$1,887,600 $125.84 p/Share
15,000 Reduced 0.71%
2,097,209 Common Stock
Jun 28 2023
SELL
Open market or private sale
$1,819,950 $121.33 p/Share
15,000 Reduced 0.71%
2,112,209 Common Stock
Jun 21 2023
SELL
Open market or private sale
$1,836,600 $122.44 p/Share
15,000 Reduced 0.7%
2,127,209 Common Stock
Jun 14 2023
SELL
Open market or private sale
$1,900,950 $126.73 p/Share
15,000 Reduced 0.7%
2,142,209 Common Stock
Jun 07 2023
SELL
Open market or private sale
$1,892,550 $126.17 p/Share
15,000 Reduced 0.69%
2,157,209 Common Stock
May 31 2023
SELL
Open market or private sale
$1,915,500 $127.7 p/Share
15,000 Reduced 0.69%
2,172,209 Common Stock
Mar 01 2023
SELL
Open market or private sale
$1,390,000 $139.0 p/Share
10,000 Reduced 0.46%
2,187,209 Common Stock
Feb 22 2023
SELL
Open market or private sale
$1,603,500 $160.35 p/Share
10,000 Reduced 0.45%
2,197,209 Common Stock
Feb 15 2023
SELL
Open market or private sale
$1,731,699 $173.17 p/Share
10,000 Reduced 0.45%
2,207,209 Common Stock
Feb 08 2023
SELL
Open market or private sale
$3,338,399 $166.92 p/Share
20,000 Reduced 0.89%
2,217,209 Common Stock
Jan 25 2023
SELL
Open market or private sale
$1,943,300 $194.33 p/Share
10,000 Reduced 0.44%
2,237,209 Common Stock
Jan 18 2023
SELL
Open market or private sale
$2,002,000 $200.2 p/Share
10,000 Reduced 0.44%
2,247,209 Common Stock
Jan 11 2023
SELL
Open market or private sale
$1,885,700 $188.57 p/Share
10,000 Reduced 0.44%
2,257,209 Common Stock
Jan 04 2023
SELL
Open market or private sale
$1,821,500 $182.15 p/Share
10,000 Reduced 0.44%
2,267,209 Common Stock
Dec 21 2022
SELL
Open market or private sale
$2,017,000 $201.7 p/Share
10,000 Reduced 0.44%
2,277,209 Common Stock

Also insider at

MCRB
Seres Therapeutics, Inc. Healthcare
RUBY
Rubius Therapeutics, Inc. Healthcare
EVLO
Evelo Biosciences, Inc. Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
AFEYAN NOUBAR

Afeyan Noubar

Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA